The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Correlates of Low Testosterone and Symptomatic Androgen Deficiency in a Population-Based Sample
Open accessAbstract
CONTEXT: Risk factors for low testosterone and symptomatic androgen deficiency (AD) may be modifiable. OBJECTIVE: Our objective was to examine demographic, anthropometric, and medical correlates of low testosterone and symptomatic AD. DESIGN: Data were used from the Boston Area Community Health Survey, an epidemiological study conducted from 2002-2005. SETTING: Data were obtained from a community-based random sample of racially and ethnically diverse men. PATIENTS OR OTHER PARTICIPANTS: Data were available for 1822 men. MAIN OUTCOME MEASURES: Multivariate logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for associations of covariates with 1) low testosterone and 2) symptomatic AD. The operational definition of low testosterone was serum total testosterone less than 300 ng/dl and free testosterone less than 5 ng/dl; symptomatic AD was defined as the additional presence of symptoms: any of low libido, erectile dysfunction, or osteoporosis or two or more of sleep disturbance, depressed mood, lethargy, or diminished physical performance. RESULTS: Factors associated with low testosterone included age (OR = 1.36; 95% CI= 1.11-1.66, per decade), low per-capita income ($6000 or less per household member vs. more than $30,000; OR = 2.86; 95% CI = 1.39-5.87), and waist circumference (per 10-cm increase; OR = 1.75; 95% CI = 1.45-2.12). Only age (OR = 1.36; 95% CI = 1.04-1.77), waist circumference (OR = 1.88; 95% CI = 1.44-2.47), and health status (OR = 0.21; 95% CI = 0.05-0.92, excellent vs. fair/poor) were associated with our construct of symptomatic AD. Of all variables, waist circumference was the most important contributor in both models. CONCLUSIONS: Waist circumference is a potentially modifiable risk factor for low testosterone and symptomatic AD. Manifestation of symptoms may be a consequence of generally poor health status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a cross-sectional analysis among 1822 men from the Boston Area Community Health cohort, central adiposity was the strongest risk factor for symptomatic androgen deficiency, overriding age and overall health status (19).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
Analysis of Incomplete Multivariate Data
Booth, D. E., & Schafer, J. L. (2000) · Technometrics · doi:10.2307/1271466 · Cited by 5,627
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
The physical activity scale for the elderly (PASE): Development and evaluation
Washburn, R. A., Smith, K. W., Jette, A. M., & Janney, C. A. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90053-4 · Cited by 3,256
Rosen, R., Cappelleri, J. C., Smith, M., Lipsky, J., & Peña, B. (1999) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900472 · Cited by 3,095
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Self-citationRosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176
Södergard, R., Bäckström, T., Shanbhag, V., & Carstensen, H. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90038-3 · Cited by 1,080
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Prevalence of hypogonadism in males aged at least 45 years: the HIM study
MULLIGAN, T., FRICK, M. F., ZURAW, Q. C., STEMHAGEN, A., & MCWHIRTER, C. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.00992.x · Cited by 767
Coefficients of Determination for Multiple Logistic Regression Analysis
Menard, S. (2000) · The American Statistician · doi:10.1080/00031305.2000.10474502 · Cited by 739
Prevalence of Symptomatic Androgen Deficiency in Men
Araujo, A. B., Esche, G. R., Kupelian, V., O’Donnell, A. B., Travison, T. G., Williams, R. E., Clark, R. V., & McKinlay, J. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1245 · Cited by 720
Self-citationTurvey, C., Wallace, R. B., & Herzog, R. (1999) · International Psychogeriatrics · doi:10.1017/s1041610299005694 · Cited by 716
Espey, D. K., Wu, X., Swan, J., Wiggins, C. L., Jim, M. A., Ward, E., Wingo, P. A., Howe, H. L., Ries, L. A. G., Miller, B. A., et al. (2007) · Cancer · doi:10.1002/cncr.23044 · Cited by 578
Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes
Kapoor, D., Aldred, H., Clark, S., Channer, K. S., & Jones, T. H. (2007) · Diabetes Care · doi:10.2337/dc06-1426 · Cited by 493
Travison, T. G., Araujo, A. B., Kupelian, V., O’Donnell, A. B., & McKinlay, J. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1859 · Cited by 410
Self-citationEndogenous sex hormones in men aged 40-80 years
Muller, M., den Tonkelaar, I., Thijssen, J., Grobbee, D., & van der Schouw, Y. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490583 · Cited by 346
Niskanen, L., Laaksonen, D. E., Punnonen, K., Mustajoki, P., Kaukua, J., & Rissanen, A. (2004) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00335.x · Cited by 275
Marriage, Divorce, and Male Testosterone
Mazur, A., & Michalek, J. E. (1998) · Social Forces · doi:10.1093/sf/77.1.315 · Cited by 256
Lower endogenous androgens predict central adiposity in men
Khaw, K., & Barrett-Connor, E. L. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90012-f · Cited by 247
Gapstur, S. M., Gann, P. H., Kopp, P. A., Colangelo, L. A., Longcope, C., & Liu, K. (2002) · PubMed · Cited by 247
Cohen, P. G. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0624 · Cited by 245
SUDAAN language manual, release 10.0
Barnwell, B., Bieler, G. S., & Witt, M. (2008) · Cited by 237
Waist Circumference and Testosterone Levels in Community Dwelling Men. The Tromsø Study
Svartberg, J., von Mühlen, D., Sundsfjord, J., & Jorde, R. (2004) · European Journal of Epidemiology · doi:10.1023/b:ejep.0000036809.30558.8f · Cited by 229
Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men
Tsai, E., Boyko, E. J., Leonetti, D., & Fujimoto, W. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801183 · Cited by 221
McKinlay, J. B., & Link, C. L. (2007) · European Urology · doi:10.1016/j.eururo.2007.03.013 · Cited by 150
Self-citationSerum androgen levels in black, Hispanic, and white men
Litman, H. J., Bhasin, S., Link, C. L., Araujo, A. B., & McKinlay, J. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0037 · Cited by 127
Self-citationPrevalence of and risk factors for androgen deficiency in middle-aged men in Hong Kong
Wong, S. Y. S., Chan, D. C. C., Hong, A. W. L., & Woo, J. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.019 · Cited by 49
Trends and regional differences in testosterone prescribing in Australia, 1991–2001
Handelsman, D. J. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06364.x · Cited by 48
Testosterone in older men after the Institute of Medicine Report: where do we go from here?
Harman, S. M. (2005) · Climacteric · doi:10.1080/13697130500118001 · Cited by 46
Risks of testosterone replacement therapy in ageing men
TAN, R. S.-H., & Salazar, J. A. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.6.599 · Cited by 41
Guideline for Male Testosterone Therapy: A Clinician’s Perspective
Morgentaler, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2629 · Cited by 34
Testosterone replacement therapy and prostate cancer: A word of caution
Brand, T. C., Canby‐Hagino, E., & Thompson, I. M. (2007) · Current Urology Reports · doi:10.1007/s11934-007-0004-x · Cited by 21
Guideline for Male Testosterone Therapy: A European Perspective
Wu, F. C. W. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2799 · Cited by 18
Male menopause-time for a decent burial?
McKinlay, J. B., Travison, T. G., de Araújo, A. B., & Kupelian, V. A. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31815708ee · Cited by 16
Self-citation
Cited by
Sorted by citations
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Low Testosterone in Men with Type 2 Diabetes: Significance and Treatment
Grossmann, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0118 · Cited by 350
Basaria, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61126-5 · Cited by 328
Lowered testosterone in male obesity: Mechanisms, morbidity and management
Grossmann, M., Tang Fui, M., & Dupuis, P. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122365 · Cited by 293
Grossmann, M., & Matsumoto, A. M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3580 · Cited by 246
Metadata
- Authors
- Hall, S. A., Esche, G. R., Araujo, A. B., Travison, T. G., Clark, R. V., Williams, R. E., & McKinlay, J. B.
- Affiliations
- New England Research Institutes (US)
- New England Research Institutes (S.A.H., G.R.E., A.B.A., T.G.T., J.B.M.), Watertown, Massachusetts 02474
- GlaxoSmithKline (United States) (US)
- Corresponding author
- Hall, Susan A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-10-01
- Volume
- 93
- Issue
- 10
- Pages
- 3870-3877
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2579652
- OpenAlex
- W2163966418
- Cited by
- 167
- References
- 38
- Citations by year
- 2025: 7 · 2024: 7 · 2023: 5 · 2022: 12 · 2021: 9 · 2020: 14 · 2019: 8 · 2018: 11 · 2017: 16 · 2016: 10 · 2015: 8 · 2014: 13 · 2013: 12 · 2012: 10
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GlaxoSmithKline
- New England Research Institutes
- National Institute on Aging (R01AG020727)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK56842, U01DK056842, R01DK056842)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen deficiency, waist circumference, risk factors, per capita income, age, health status, free testosterone, serum total testosterone, erectile dysfunction, low libido, community-dwelling men
- MeSH terms
- Adult, Aged, Androgens, Body Composition, Cross-Sectional Studies, Demography, Endocrine System Diseases, Female, Humans, Life Style, Male, Middle Aged, Models, Theoretical, Risk Factors, Testosterone, Comorbidity, Multivariate Analysis, Waist-Hip Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review